Finding accredited CPD
In this presentation, Dr Tilenka Thynne examines evolving areas in the use of SGLT2 inhibitors-associated ketoacidosis in diabetic and non-diabetic populations where these agents are increasingly prescribed. She explores key aspects of managing euglycemic ketoacidosis and critically evaluates whether the protocols are truly fit for purpose. She also reviews the recent clinical guidelines on GLP-1/GIP receptor agonists, highlighting key recommendations and the supporting evidence.
ASANSC 2024 - Darwin Seminars Series for Anaesthetists.
Authors: ASA, Dr Tilenka Thynne
This activity is accepted by CPD Home as a Domain 1: Educational Activity in alignment with the CPD Program Guide.
Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.
You have to log in to see the content of this module.
Provided by
Accepted by
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)
